Clinical Trial Update: An Evaluation of the Onset and Duration of Action of AKF-1 Ophthalmic Solution in Treating Acute Allergic Conjunctivitis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing onset and duration of AKF-1 Ophthalmic Solution for acute allergic conjunctivitis has completed. The snippet does not provide trial resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis

Drugs mentioned

• AKF-1 Ophthalmic Solution

Snippet

Sponsor: Akorn, Inc. | Conditions: Allergic Conjunctivitis | Phase 3 | Status: COMPLETED